The study of NUGA MRT-II relief for low back muscular pain

The study of NUGA MRT-II relief for low back muscular pain: a randomised, patient-assessor, blind, two arm sham device controlled pilot trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13816277

Enrollment

Registered

2011-06-10

Start date

2010-09-03

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back muscular pain Musculoskeletal Diseases Dorsalgia

Interventions

Treatment group : Treated with real equipment for 3 times a week. It takes 10 minutes for each treatment. No other treatments will be applied during this trial. Treating point : Choose lumbar acupoi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Genders Eligible for Study : Both 2. Patients who have been undergo chronic low back pain for chief complain over 3 months 3. Patient whose age is from 18 to 65 4. Patients whose neurology examination is normal 5. Patients whose bothersomeness for the last week before the participation of the treatment is over Visual Analogue Scale (VAS) 5 6. Patients who are diagnosed as nonspecific low back pain

Exclusion criteria

Exclusion criteria: 1. Patients who have radicular pain 2. Patients who are diagnosed with specific disease which cause low back pain such as metastatic cancer, vertebral fracture, spinal infection, inflammatory spondylitis 3. Patients who are diagnosed with other chronic disease which could affect the result such as cardiovascular disease, diabetic neuropathy, active hepatitis, fibromyalagia, rheumatic arthritis, dementia, haemorrhagic disease, epilepsy 4. Patients who have had or would have spinal surgery 5. Patients who have other skeletomuscular pain as chief complain 6. Patients who have undergone acupuncture treatment for low back pain in last one month 7. Patients who are taking corticosteroids, narcotics, muscle relaxant, anticoagulant drug, herbal medicine for low back pain or other non-propal drugs

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS) for bothersomeness : measured at baseline, every visit during 2 weeks and after 3 weeks	—

Secondary

Measure	Time frame
1. The Korean version of the Roland-Morris disability questionnaire 2. VAS for pain intensity 3. The Korean version of Oswestry Disability Index (ODI) 4. The Korean version of EuroQol 5-Dimension (EQ-5D) 5. The Korean version of SF-36 for quality of life 6. The Korean version of Beck's depression inventory (BDI) 7. Medication use Measured at baseline, every visit during 2 weeks and after 3 weeks	—

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026